Galantamine Hydrobromide

　　This product is an anticholinesterase agent with relatively weak cholinesterase‑inhibiting activity. It can cross the blood–brain barrier, resulting in pronounced effects on the central nervous system. It restores impaired neuromuscular transmission and improves paralysis associated with various peripheral neuromuscular disorders. With a broad therapeutic spectrum, low toxicity, and good patient tolerability, it is clinically indicated primarily for the treatment of post‑poliomyelitis sequelae, muscular atrophy, and myasthenia gravis. It may also be used for cerebral palsy in children, traumatic sensorimotor deficits, polyneuritis, and radiculitis.

　 　CAS Number: 1953-04-4

　　 EINECS number: 217-780-5

　 　Molecular formula: C17H21NO3.HBr

　　Molecular weight: 368.27

　 　Characteristics: White crystalline powder; odorless, with a bitter taste.

　 　Solubility: Soluble in water, slightly soluble in ethanol, and insoluble in chloroform and diethyl ether.

　　 Melting point: 258℃~264℃

　　Boiling point: 439.336°C at 760 mmHg

　　 Flash point: 2 19.503°C

　　 Vapor pressure: 0mmHg at 25°C

　 　Testing method: High-Performance Liquid Chromatography Detector (HPLC)

　　 Specifications: (HPLC)≥99%

　 　Save: Store in a sealed container, in a cool, dry place, protected from light and high temperatures. Shelf life: two years.